These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6229228)

  • 1. Ancrod in systemic lupus erythematosus with thrombosis. Clinical and fibrinolysis effects.
    Dosekun AK; Pollak VE; Glas-Greenwalt P; Kant KS; Penovich P; Lebron-Berges A; Weiss MA; Levinson JE
    Arch Intern Med; 1984 Jan; 144(1):37-42. PubMed ID: 6229228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ancrod: normalization of fibrinolytic enzyme abnormalities in patients with systemic lupus erythematosus and lupus nephritis.
    Glas-Greenwalt P; Kant KS; Dosekun A; Frazier J; Allen C; Pollak VE
    J Lab Clin Med; 1985 Jan; 105(1):99-107. PubMed ID: 3871465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lupus nephritis with thrombosis and abnormal fibrinolysis: effect of ancrod.
    Kant KS; Pollak VE; Dosekun A; Glas-Greenwalt P; Weiss MA; Glueck HI
    J Lab Clin Med; 1985 Jan; 105(1):77-88. PubMed ID: 3968467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
    J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment by defibrination with ancrod in a patient with hyperacute renal allograft failure and a deficiency of plasma prostacyclin stimulating factor.
    Dosekun AK; First MR; Chandran PK; Kant KS; Glas-Greenwalt P; Weiss MA; Alexander JW; Pollak VE
    Clin Nephrol; 1982 Aug; 18(2):101-5. PubMed ID: 6754189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolysis in glomerulonephritis treated with ancrod: renal functional, immunologic and histopathologic effects.
    Kim S; Wadhwa NK; Kant KS; Pollak VE; Glas-Greenwalt P; Weiss MA; Hong CG
    Q J Med; 1988 Nov; 69(259):879-905. PubMed ID: 3078212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of a plasma factor stimulating vascular prostacyclin generation in patients with lupus nephritis and glomerular thrombi and its correction by ancrod: in-vivo and in-vitro observations.
    Kant KS; Dosekun AK; Chandran KG; Glas-Greenwalt P; Weiss MA; Pollak VE
    Thromb Res; 1982 Sep; 27(6):651-8. PubMed ID: 6758185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ancrod: clinical indications and methods of use.
    Wright JG; Geroulakos G
    Semin Vasc Surg; 1996 Dec; 9(4):315-28. PubMed ID: 8958608
    [No Abstract]   [Full Text] [Related]  

  • 9. Ancrod causes rapid thrombolysis in patients with acute stroke.
    Pollak VE; Glas-Greenwalt P; Olinger CP; Wadhwa NK; Myre SA
    Am J Med Sci; 1990 May; 299(5):319-25. PubMed ID: 2186630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator inhibitor: a regulator of ancrod-induced fibrin deposition in rabbits.
    Krishnamurti C; Barr CF; Hassett MA; Young GD; Alving BM
    Blood; 1987 Mar; 69(3):798-803. PubMed ID: 3101764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy-related renal failure.
    Kincaid-Smith P; Fairley KF; Kloss M
    Q J Med; 1988 Oct; 68(258):795-815. PubMed ID: 3151939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral urokinase: absorption, mechanisms of fibrinolytic enhancement and clinical effect on cerebral thrombosis.
    Abe T
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):122-36. PubMed ID: 2427393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predisposing factors to thrombosis in systemic lupus erythematosus: possible relation to endothelial cell damage.
    Angles-Cano E; Sultan Y; Clauvel JP
    J Lab Clin Med; 1979 Aug; 94(2):312-23. PubMed ID: 458249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retinal vascular lesions in systemic lupus erythematosus and secondary antiphospholipid syndrome].
    Ermakova NA; Alekberova ZS; Reshetniak TM; Kalashnikova LA; Kosheleva NM
    Vestn Oftalmol; 2005; 121(5):31-6. PubMed ID: 16274063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatic thrombotic events among Egyptian patients with systemic lupus erythematosus: special consideration for renal vein thrombosis.
    Shahin AA; Mostafa H; Sami H; Shahin HA
    Z Rheumatol; 2003 Jun; 62(3):246-50. PubMed ID: 12827401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombolytic therapy with urokinase in two systemic lupus erythematosus patients with deep vein thrombosis].
    Hu YQ; Yang PZ; Zuo XX
    Hunan Yi Ke Da Xue Xue Bao; 2002 Dec; 27(6):575-6. PubMed ID: 12658949
    [No Abstract]   [Full Text] [Related]  

  • 18. Ancrod: understanding the agent.
    Illig KA; Ouriel K
    Semin Vasc Surg; 1996 Dec; 9(4):303-14. PubMed ID: 8958607
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies.
    Cheunsuchon B; Rungkaew P; Chawanasuntorapoj R; Pattaragarn A; Parichatikanond P
    Nephrology (Carlton); 2007 Oct; 12(5):474-80. PubMed ID: 17803471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Extensive cerebral venous thrombosis resistant to heparin: local fibrinolysis with urokinase].
    Smadja D; Raynaud M; Mehdaoui H; Poey C; Drault JN; Ridarch A; Tixier F; Vernant JC; Mas JL
    Rev Neurol (Paris); 1997 May; 153(4):271-4. PubMed ID: 9296147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.